Institute for Health Services Research in Dermatology and Nursing (IVDP), University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany.
JMIR Dermatol. 2024 Sep 3;7:e57172. doi: 10.2196/57172.
Although several digital health interventions (DHIs) have shown promise in the care of skin diseases their uptake in Germany has been limited. To fully understand the reasons for the low uptake, an in-depth analysis of patients' and health care providers' barriers and facilitators in dermatology is needed.
The objective of this study was to explore and compare attitudes, acceptability, barriers, and facilitators of patients, dermatologists, and nurses toward DHIs in dermatology.
We conducted 6 web-based focus groups each with patients (n=34), dermatologists (n=30), and nurses (n=30) using a semistructured interview guide with short descriptions of DHIs described in the literature. A content analysis was performed using deductive constructs, following the unified theory of acceptance and use of technology framework, and inductive categories.
Patients identified many positive performance expectancies, such as reduced travel times and improvement in follow-up appointments. Dermatologists also stated positive effects (eg, promotion of standardized care), but also negative implications of health care digitalization (eg, increased workload). All stakeholders reported that a DHI should bring additional value to all stakeholders. A lack of digital competence among patients was identified as the major barrier to adoption by all 3 groups. Nurses and dermatologists want apps that are easy to use and easy to implement into their daily routines. Trust in selected institutions, colleagues, and physicians was identified as a facilitator. Patients reported their dependence on the dermatologists' acceptance. All groups expressed concerns about data privacy risks and dermatologists stated insecurities toward data privacy laws.
To ensure successful digitalization in dermatology, apps should be user-friendly, adapted to users' skill levels, and beneficial for all stakeholders. The incorporation of dermatologists' perspectives is especially important as their acceptance may impact use among patients and nurses. DHIs should ensure and be transparent about data privacy. The found barriers and facilitators can be used for implementation strategies.
尽管有几种数字健康干预措施(DHIs)在皮肤病护理方面显示出了前景,但它们在德国的采用率却有限。为了充分了解采用率低的原因,需要深入分析皮肤科患者和医疗保健提供者的障碍和促进因素。
本研究旨在探讨和比较患者、皮肤科医生和护士对皮肤病学中 DHIs 的态度、可接受性、障碍和促进因素。
我们使用文献中描述的数字健康干预措施的简短描述,进行了 6 次基于网络的焦点小组讨论,每次讨论都有患者(n=34)、皮肤科医生(n=30)和护士(n=30)参加,采用半结构化访谈指南。使用统一的技术接受和使用理论框架和归纳类别进行内容分析。
患者确定了许多积极的绩效期望,例如减少旅行时间和改善随访预约。皮肤科医生也表示了积极的影响(例如,促进标准化护理),但也指出了医疗数字化的负面影响(例如,增加工作量)。所有利益相关者都表示,DHIs 应该为所有利益相关者带来额外的价值。所有 3 组都认为患者缺乏数字能力是采用的主要障碍。护士和皮肤科医生希望应用程序易于使用并且易于融入他们的日常工作中。对选定机构、同事和医生的信任被认为是一个促进因素。患者报告说他们依赖皮肤科医生的接受。所有组都对数据隐私风险表示担忧,皮肤科医生表示对数据隐私法缺乏信心。
为了确保皮肤病学的数字化成功,应用程序应该易于使用,适应用户的技能水平,并对所有利益相关者有益。纳入皮肤科医生的观点尤为重要,因为他们的接受程度可能会影响患者和护士的使用。DHIs 应确保并透明数据隐私。发现的障碍和促进因素可用于实施策略。